Corcept Therapeutics
Corcept Therapeutics

Dividends • Corcept Therapeutics

CORT

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding Date
Payment
Value ($)
Frequency
2/28/2024
3/13/2024
0,188
Quarterly
11/29/2023
12/13/2023
0,188
Quarterly
8/30/2023
9/12/2023
0,188
Quarterly
5/30/2023
6/13/2023
0,188
Quarterly
2/27/2023
3/14/2023
0,125
Quarterly